Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2. The research is published in Communications Biology, a Nature journal.
By the thousands, U.S. service members are refusing or putting off the COVID-19 vaccine as frustrated commanders scramble to knock down internet rumors and find the right pitch that will persuade troops to get the shot.
Rigoberto Montesinos, a veteran of the Bay of Pigs invasion in Cuba, was so worried about side effects from the COVID-19 vaccine that he initially wasn't going to get it, relenting only when two friends died from the disease.
FEMA opened its first COVID-19 mass vaccination sites Tuesday, setting up in Los Angeles and Oakland as part of an effort by the Biden administration to get shots into arms more quickly and reach minority communities hit hard by the outbreak.
The makers of COVID-19 vaccines are figuring out how to tweak their recipes against worrisome virus mutations — and regulators are looking to flu as a blueprint if and when the shots need an update.
Department of Veterans Affairs (VA) health care facilities are receiving a one-time supplemental allocation of 200,000 Moderna COVID-19 vaccine doses this week from the Department of Health and Human Services.
At the start of the COVID-19 pandemic, the most daunting question facing the child welfare field was whether a precipitous drop in calls to child abuse hotlines across the country was masking an epidemic of abuse. With schools shut down and families under a lockdown, the fear was that child abuse cases might skyrocket.
Congressman Raul Ruiz, M.D. (CA-36) is urging retail pharmacies to join the fight for health equity in COVID-19 vaccinations. In a letter to the CVS Health CEO Larry Merlo, Dr. Ruiz called on the retail pharmacy to prioritize high-risk, underserved communities in its vaccine administration plans.
The U.S. has entered a tricky phase of the COVID-19 vaccination effort as providers try to ramp up the number of people getting first shots while also ensuring a growing number of others get second doses just when millions more Americans are becoming eligible to receive vaccines.
Evidence is mounting that having COVID-19 may not protect against getting infected again with some of the new variants. People also can get second infections with earlier versions of the coronavirus if they mounted a weak defense the first time, new research suggests.